Why Emocog
Dementia affects about 10% of the senior population and progresses over a decade. The stage of memory decline before dementia is called Mild Cognitive Impairment (MCI) and progresses over half a decade. The prevalence rate is about 25%.
Emocog develops solutions for each stage of dementia, including Cogthera, a digital therapeutic for cognitive improvement in MCI.
Research
The results of 20 years of research were published in 5 leading *SCI-indexed journals on brain disease.
*Science Citation Index (SCI): renowned journals carefully selected based on strict criteria among science and technology journals
01
Kim et al., 2021, Journal of Medical Internet Research
Smart speaker-based Metamemory Training program has improved memory, executive function, and working memory. Conversation-based training using voice can proceed free from the restraints of professional presence, location, and time. Results suggest a very high training compliance.
02
Youn et al., 2020, Journal of Clinical Medicine
According to the results of the MMT program, which was conducted on 113 patients with mild cognitive impairment (MCI), there was a significant score increase in the training group compared to the control group — in both delayed free recall and fluency scores. Additionally, subjective memory complaints (SMC) scores and the frequency of subjective memory decline in daily life were also significantly reduced.
03
Youn et al., 2019, Brain and Behavior
Based on the results of the analysis conducted on the training group of the MMT program (201 seniors aged 55 and over with subjective memory complaints), significant improvements were evident in long-term delayed free recall, fluency, and the Boston Naming Test. Among the patients that received cognitive training, neuroimaging results also show an increase in the integration of cerebral white matter and the cortical thickness of the prefrontal lobe.
04
Park et al., 2018, Scientific Reports
Based on the MMT program conducted on the elderly with subjective cognitive decline, results show significant changes in cortical thickness and cognitive function in areas composed of the right precuneus, cuneus, and posterior cingulate gyrus. Also, an increase in overall brain volume was observed.
05
Youn et al., 2011, Geropsychiatry
Development of the Korean-tailored Metamemory Training (MMT) and the investigation on the effectiveness of memory training on language memory, spatio-temporal memory, working memory, and language fluency ability. Results of conducting MMT multi-domain cognitive training show improvements in delayed recall, working memory, and fluency.
Solution 1
Emocog builds an ecosystem to care for the entire journey from screening, diagnosis and treatment of dementia. To overcome the physical constraints of not being able to care for every patient every day, we propose innovative solutions utilizing digital technology.
*Digital Health Applications (DiGA) are virtual medical products that are available as apps for mobile devices or as browser applications. Cogthera DE can quickly enter the market and receive very high insurance rates through this process.
LAUNCH
LAUNCH
(DiGA* fast track process in Germany)
LAUNCH
PROTOTYPE & TEST
PROTOTYPE & TEST
Mobile cognitive assessment serviceto help screen for dementia risk
MemoryPick is a digital screening tool that helps users detect early signs of cognitive decline. It evaluates memory and executive function, which are the first cognitive areas to decline due to dementia, as well as subjective cognitive decline and depression.
At the end of the test, it shows an instant results report representing the user’s brain health. Based on the results, it recommends memory strategies to help daily life and lifestyle habits to keep the brain healthy.
It is a responsive web-based online test that can be performed on various devices and operating systems through a QR or a URL.
The test takes only about 5 minutes, providing comfortable and easy-to-use content based on simple words and shapes.
By accounting for differences in cognitive function by age, education, gender, and more, we built large-scale normative data to improve the accuracy of results.
Digital Therapeutics(DTx) for delaying cognitive declinein patients with mild cognitive impairment
Cogthera constantly monitors patients’ cognitive functions and provides personalized cognitive training to strengthen the neural networks and increase the *cognitive reserve.
It was designated as an Innovative Medical Device by MFDS and became the first cognitive intervention treatment software for MCI to be designated as an Innovative Medical Device in Korea.
Conversation-based interface using vocal cues, made for the convenience of patients with early cognitive decline.
The difficulty level automatically adjusts based on the patient's performance.
Designed for daily use under the guidance and prescription of a healthcare professional.
In addition to clinical trials in Korea, Cogthera is simultaneously pursuing German DiGA (Digital Health Applications). DiGA is a fast-track system by the German regulator BfArM, with an advantage of fast market entry and high reimbursement rate.
Solution 2
With Happymind, the developer of CAT, which has a high market share in Korea, we are rapidly growing by sharing development technology, know-how, and networks accumulated over the years.
Happymind evaluates problems related to learning disorders such as attention deficit, poor reading skills and poor math skills, and provides solutions to them.
LAUNCH
LAUNCH
LAUNCH
DATA COLLECTION & ANALYSIS
CONCEPT DEVELOPMENT
Happymind Comprehensive Attention Testhelps objective assessment of attention
Happymind’s CAT (Comprehensive Attention Test) is a web-based test to comprehensively assess attention in children, adolescents, and adults.
It examines 5 different types of attention in 6 different tests: simple attention, selective attention, sustained attention, divided attention, and working memory. This allows you to assess whether you have attention level issues in each area.
Completed a standardized study of 1,062 people aged 4–49, providing more objective results
The only attention test certified by the Korean Academy of Child and Adolescent Psychiatry
Comprehensive Learning Test for early detectionof dyslexia and dyscalculia in children and adolescents
Happymind’s CLT (Comprehensive Learning Test) is a web-based test for the early screening, diagnosis and measurement of improvement in children and adolescents at risk for dyslexia and dyscalculia.
It consists of small tests in reading and calculation.
CLT-R: 9 Tests for Dyslexia
Word Reading / Paragraph Reading / Sound Blending Nonword Repetition / Rapid Automatized Naming / Letter-Sound Matching Orthographic Awareness / Visual Attention / Digit Span
CLT-M: 7 Tests for Dyscalculia
Computation / Magnitude Comparing / Distance Comparing / Enumeration / Estimation Working Memory / Digit Span
Validated for reliability and accuracy through standardized studies with children and adolescents in Korea
Results can be interpreted in conjunction with intelligence tests, attention tests, and other academic achievement tests to increase the reliability of learning disorder diagnosis
Leadership
The three founders of Emocog are all medical professionals. Our employees are also from leading companies around the world, united by a global mindset and a strong passion for what we do.
In addition, we are partnering with our German team, with backgrounds and experience in various fields such as data technology and medical engineering, to enter the European and global markets.
Co-CEO & Founder
Co-CEO & Founder
Scientific Board & Founder
Happymind CEO
Medical Advisor
Co-CEO & Founder
Co-CEO & Founder
Scientific Board & Founder
Happymind CEO
Medical Advisor
CTO Korea
COO Europe
CTO Korea
COO Europe
CEO Europe
CEO Europe
Company
Emocog has raised significant funding and built strong partnerships with leading companies in Korea and abroad.
Series B funding round
Pre-Series A Funding Round
Seed Funding Round
Partners
News
